Equities analysts forecast that Iqvia Holdings Inc (NYSE:IQV) will announce sales of $2.44 billion for the current fiscal quarter, according to Zacks. Seven analysts have made estimates for Iqvia’s earnings. The highest sales estimate is $2.45 billion and the lowest is $2.43 billion. Iqvia reported sales of $1.91 billion during the same quarter last year, which suggests a positive year over year growth rate of 27.7%. The company is expected to announce its next earnings results on Wednesday, May 2nd.
According to Zacks, analysts expect that Iqvia will report full year sales of $2.44 billion for the current fiscal year, with estimates ranging from $10.11 billion to $10.16 billion. For the next fiscal year, analysts forecast that the business will report sales of $10.48 billion per share, with estimates ranging from $9.00 billion to $10.82 billion. Zacks’ sales calculations are an average based on a survey of research analysts that cover Iqvia.
Iqvia (NYSE:IQV) last posted its quarterly earnings results on Wednesday, February 14th. The medical research company reported $1.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.34 by ($0.02). Iqvia had a net margin of 13.44% and a return on equity of 13.03%. The business had revenue of $2.16 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same period in the previous year, the business posted $1.09 EPS. The business’s revenue for the quarter was up 10.7% compared to the same quarter last year.
In other news, Director Michael J. Evanisko sold 816 shares of Iqvia stock in a transaction on Monday, March 5th. The stock was sold at an average price of $100.00, for a total transaction of $81,600.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider James H. Erlinger III sold 10,000 shares of Iqvia stock in a transaction on Monday, February 26th. The stock was sold at an average price of $100.00, for a total value of $1,000,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 30,816 shares of company stock worth $3,093,400 over the last quarter. Company insiders own 6.00% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Franklin Street Advisors Inc. NC bought a new stake in shares of Iqvia during the 4th quarter worth $7,446,000. Chevy Chase Trust Holdings Inc. bought a new stake in Iqvia in the 4th quarter valued at about $14,462,000. Icon Advisers Inc. Co. bought a new stake in Iqvia in the 4th quarter valued at about $852,000. BlackRock Inc. bought a new stake in Iqvia in the 4th quarter valued at about $942,532,000. Finally, Nisa Investment Advisors LLC bought a new stake in Iqvia in the 4th quarter valued at about $920,000. Institutional investors own 92.34% of the company’s stock.
Shares of Iqvia (NYSE:IQV) opened at $105.93 on Tuesday. Iqvia has a 52-week low of $76.80 and a 52-week high of $110.67. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.19 and a quick ratio of 1.19. The stock has a market cap of $22,030.00, a price-to-earnings ratio of 70.62, a P/E/G ratio of 2.70 and a beta of 0.64.
ILLEGAL ACTIVITY WARNING: “$2.44 Billion in Sales Expected for Iqvia Holdings Inc (IQV) This Quarter” was first posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was stolen and reposted in violation of US & international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/13/2-44-billion-in-sales-expected-for-iqvia-holdings-inc-iqv-this-quarter.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.